BRPI0820832A2 - Composto, uso de um composto, método de tratamento de câncer, composição farmacêutica, kit , e, uso de uma composição farmacêutica. - Google Patents
Composto, uso de um composto, método de tratamento de câncer, composição farmacêutica, kit , e, uso de uma composição farmacêutica.Info
- Publication number
- BRPI0820832A2 BRPI0820832A2 BRPI0820832-8A BRPI0820832A BRPI0820832A2 BR PI0820832 A2 BRPI0820832 A2 BR PI0820832A2 BR PI0820832 A BRPI0820832 A BR PI0820832A BR PI0820832 A2 BRPI0820832 A2 BR PI0820832A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- kit
- treatment method
- cancer treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US601007P | 2007-12-14 | 2007-12-14 | |
PCT/SE2008/051450 WO2009078794A1 (en) | 2007-12-14 | 2008-12-12 | Compounds for use in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0820832A2 true BRPI0820832A2 (pt) | 2015-06-16 |
Family
ID=40795764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0820832-8A BRPI0820832A2 (pt) | 2007-12-14 | 2008-12-12 | Composto, uso de um composto, método de tratamento de câncer, composição farmacêutica, kit , e, uso de uma composição farmacêutica. |
Country Status (13)
Country | Link |
---|---|
US (2) | US8377969B2 (pt) |
EP (1) | EP2224925B1 (pt) |
JP (1) | JP5484352B2 (pt) |
KR (2) | KR101678865B1 (pt) |
CN (1) | CN101917993B (pt) |
AU (1) | AU2008339091B2 (pt) |
BR (1) | BRPI0820832A2 (pt) |
CA (1) | CA2708113C (pt) |
ES (1) | ES2552734T3 (pt) |
HK (1) | HK1151971A1 (pt) |
IL (1) | IL206189A (pt) |
RU (1) | RU2491282C2 (pt) |
WO (1) | WO2009078794A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2224925B1 (en) | 2007-12-14 | 2015-09-09 | Pledpharma AB | Compounds for use in the treatment of cancer |
WO2011004325A1 (en) * | 2009-07-06 | 2011-01-13 | Pledpharma Ab | Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound |
JP6131271B2 (ja) | 2012-01-05 | 2017-05-17 | プレッドファルマ・アーベー | カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法 |
US20150313921A1 (en) * | 2012-11-02 | 2015-11-05 | Pledpharma Ab | Cancer Treatment Methods |
WO2018087347A1 (en) * | 2016-11-14 | 2018-05-17 | Karlsson-Tuner Invest As | Use of non-transition metal coordinated dipyridoxyl compounds to prevent and treat chemotherapy-induced psn |
CN108658430B (zh) * | 2018-05-18 | 2020-08-25 | 佛山市金凯地过滤设备有限公司 | 一种污泥深度脱水的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19532625C2 (de) * | 1995-09-04 | 2000-04-20 | Steigerwald Arzneimittelwerk | Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte |
GB9613182D0 (en) | 1996-06-24 | 1996-08-28 | Nycomed Imaging As | Method |
GB9727224D0 (en) | 1997-12-23 | 1998-02-25 | Nycomed Imaging As | Method |
ATE277038T1 (de) * | 1997-12-23 | 2004-10-15 | Amersham Health As | Stickstoffoxid freisetzende chelatbildner und ihre therapeutische verwendung |
FR2823977B1 (fr) | 2001-04-26 | 2006-12-01 | Univ Rene Descartes | Utilisation du mangafodipir dans le traitement des effets d'un stress oxydatif |
FR2863892B1 (fr) * | 2003-12-18 | 2007-05-11 | Univ Paris Descartes | Utilisation de mimetiques de la superoxyde dismutase et de la glutathion reductase comme anti-cancereux |
US20070148154A1 (en) * | 2004-12-17 | 2007-06-28 | Universite Rene Descartes (Paris V) | Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs |
EP2224925B1 (en) | 2007-12-14 | 2015-09-09 | Pledpharma AB | Compounds for use in the treatment of cancer |
-
2008
- 2008-12-12 EP EP08863324.3A patent/EP2224925B1/en not_active Not-in-force
- 2008-12-12 KR KR1020107012992A patent/KR101678865B1/ko active IP Right Grant
- 2008-12-12 JP JP2010537900A patent/JP5484352B2/ja not_active Expired - Fee Related
- 2008-12-12 WO PCT/SE2008/051450 patent/WO2009078794A1/en active Application Filing
- 2008-12-12 ES ES08863324.3T patent/ES2552734T3/es active Active
- 2008-12-12 CN CN2008801203222A patent/CN101917993B/zh not_active Expired - Fee Related
- 2008-12-12 AU AU2008339091A patent/AU2008339091B2/en not_active Ceased
- 2008-12-12 CA CA2708113A patent/CA2708113C/en not_active Expired - Fee Related
- 2008-12-12 KR KR1020167007884A patent/KR101678866B1/ko active IP Right Grant
- 2008-12-12 US US12/808,144 patent/US8377969B2/en active Active
- 2008-12-12 RU RU2010129038/04A patent/RU2491282C2/ru active
- 2008-12-12 BR BRPI0820832-8A patent/BRPI0820832A2/pt not_active IP Right Cessation
-
2010
- 2010-06-06 IL IL206189A patent/IL206189A/en active IP Right Grant
-
2011
- 2011-06-14 HK HK11106063.6A patent/HK1151971A1/xx not_active IP Right Cessation
-
2013
- 2013-02-16 US US13/769,298 patent/US8633174B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2009078794A1 (en) | 2009-06-25 |
CN101917993B (zh) | 2013-08-21 |
JP5484352B2 (ja) | 2014-05-07 |
JP2011506434A (ja) | 2011-03-03 |
US20100298271A1 (en) | 2010-11-25 |
HK1151971A1 (en) | 2012-02-17 |
KR20100103510A (ko) | 2010-09-27 |
EP2224925B1 (en) | 2015-09-09 |
ES2552734T3 (es) | 2015-12-01 |
US8377969B2 (en) | 2013-02-19 |
AU2008339091B2 (en) | 2014-08-07 |
EP2224925A4 (en) | 2011-01-12 |
RU2010129038A (ru) | 2012-01-20 |
KR101678865B1 (ko) | 2016-11-23 |
EP2224925A1 (en) | 2010-09-08 |
CN101917993A (zh) | 2010-12-15 |
US8633174B2 (en) | 2014-01-21 |
RU2491282C2 (ru) | 2013-08-27 |
KR20160036107A (ko) | 2016-04-01 |
CA2708113C (en) | 2017-08-22 |
IL206189A0 (en) | 2010-12-30 |
AU2008339091A1 (en) | 2009-06-25 |
KR101678866B1 (ko) | 2016-11-23 |
CA2708113A1 (en) | 2009-06-25 |
IL206189A (en) | 2016-06-30 |
US20130157983A1 (en) | 2013-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
BRPI0911685A2 (pt) | composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit | |
BRPI0922475A2 (pt) | composto, composição farmacêutica , método para tratar câncer, e, uso de um composto. | |
BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0819218A2 (pt) | Métodos, estojos e composições para administração de compostos farmacêuticos | |
CL2007003226A1 (es) | Compuestos derivados de piridinona; composicion farmaceutica; y uso para tratar el cancer. | |
BRPI0906576A2 (pt) | Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer | |
BRPI0820474A2 (pt) | método de tratamento de uma doença, uso de composto, e, composto | |
BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
BRPI0917001A2 (pt) | composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica | |
DK1868579T3 (da) | Farmaceutisk sammensætning omfattende en omega-carboxyaryl sunstitueret diphenylurea til behandling af cancer | |
BRPI0820568A2 (pt) | Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal | |
BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
BRPI0813770A2 (pt) | Composição, e, uso de uma composição | |
BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
BRPI0905369A2 (pt) | Composição farmacêutica, composição e kit compartimentado | |
BRPI0912539A2 (pt) | composto, composição farmacêutica , método para tratar uma doença, e, uso do composto. | |
BRPI0908635A2 (pt) | composto, composição farmacêutica e método de tratamento de câncer | |
BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0818323A2 (pt) | composição farmacêutica, uso de uma composição farmacêutica, e, método para tratar câncer. | |
BRPI0812942A2 (pt) | Composto, composição farmacêutica e uso de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: EGETIS THERAPEUTICS AB (SE) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 14A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2700 DE 04-10-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |